u/Marketspike · 21d ago5 prior · awaiting results
Three Micro/Small Caps With Near Term Catalysts: $GOVX $WYY $DRK
GeoVax is extremely oversold (RSI 26) with a pivotal 500-patient Phase 3 immune-bridging study launching in Q4 2026, with results expected mid-2027. The company's partnership with CEPI provides access to a centralized laboratory network, positioning it for potential Big Pharma attention as clinical trials progress.
At post $0.35Now $0.23-35.4% since postedas of Oct 19, 4:30 PM ET
1d-5.1%
3d-9.1%
1w-18.0%
1m—
3m—
6m—
1y—